Chemical activators of Oatp-Y encompass a diverse array of compounds that can influence the transporter's activity through various mechanisms. These activators, while not homogeneous in structure or primary function, share the ability to modulate the activity of Oatp-Y, contributing to its role in cellular transport processes. The chemical classes of these activators are broad, including but not limited to, inhibitors of other transport proteins, inducers of protein expression, modulators of receptor signaling pathways, and agents that can alter transporter phosphorylation states. Their primary modes of action on the Oatp-Y transporter involve either increasing the availability of substrates by inhibiting competing pathways or enhancing the expression of the transporter protein through the activation of nuclear receptors and upstream signaling pathways.
The methods by which these chemicals activate Oatp-Y often involve intricate cellular signaling cascades. For example, certain compounds can upregulate the expression of Oatp-Y by activating nuclear receptors, which bind to the promoter regions of genes and facilitate transcription. Others can modify transporter activity by influencing protein kinase pathways, leading to changes in transporter phosphorylation that can affect function and regulation. Some activators may alter the availability of endogenous substrates by inhibiting other transporters, thereby altering substrate concentrations in a manner that favors Oatp-Y-mediated transport. Additionally, specific chemicals may bind to receptors that indirectly modulate transporter function, showing the interconnected nature of cellular signaling and transport mechanisms. These activators are key to understanding the complex regulation of Oatp-Y and its role within the cellular transport system.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $62.00 $90.00 $299.00 $475.00 $1015.00 $2099.00 | 69 | |
Cyclosporin A is known to inhibit various OATPs. Inhibition of competing pathways might increase substrate availability for Oatp-Y activation. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $95.00 $322.00 $663.00 $1438.00 | 6 | |
Rifampicin induces certain OATPs; it might upregulate Oatp-Y activation by activating nuclear receptors that enhance gene transcription. | ||||||
Chrysin | 480-40-0 | sc-204686 | 1 g | $37.00 | 13 | |
Chrysin is a flavonoid that can influence transporters by modulating estrogen receptor signaling, which could activate Oatp-Y . | ||||||
Indomethacin | 53-86-1 | sc-200503 sc-200503A | 1 g 5 g | $28.00 $37.00 | 18 | |
As an NSAID, indomethacin impacts prostaglandin levels, which could activate Oatp-Y by changes in substrate concentration. | ||||||
Probenecid | 57-66-9 | sc-202773 sc-202773A sc-202773B sc-202773C | 1 g 5 g 25 g 100 g | $27.00 $38.00 $98.00 $272.00 | 28 | |
Probenecid is known to inhibit various OATPs, potentially increasing availability of substrates for Oatp-Y activation by competitive inhibition. | ||||||
Clofibrate | 637-07-0 | sc-200721 | 1 g | $32.00 | ||
Clofibrate activates peroxisome proliferator-activated receptors (PPARs) which may upregulate Oatp-Y activation as part of lipid regulation. | ||||||
N-Ethylmaleimide | 128-53-0 | sc-202719A sc-202719 sc-202719B sc-202719C sc-202719D | 1 g 5 g 25 g 100 g 250 g | $22.00 $68.00 $210.00 $780.00 $1880.00 | 19 | |
NEM can modify cysteine residues and could activate Oatp-Y function, leading to changes in transporter activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA activates protein kinase C (PKC) which can phosphorylate and could activate transporter proteins, possibly including Oatp-Y . | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Genistein, a tyrosine kinase inhibitor, might modify signaling pathways that regulate transporter expression and could activate Oatp-Y . | ||||||
Sulfasalazine | 599-79-1 | sc-204312 sc-204312A sc-204312B sc-204312C | 1 g 2.5 g 5 g 10 g | $60.00 $75.00 $125.00 $205.00 | 8 | |
Sulfasalazine is known to interact with certain OATPs, and could activate Oatp-Y through competitive substrate interactions. | ||||||